Cargando…
Predicting clinical response to costimulation blockade in autoimmunity
Curbing unwanted T cell responses by costimulation blockade has been a recognised immunosuppressive strategy for the last 15 years. However, our understanding of how best to deploy this intervention is still evolving. A key challenge has been the heterogeneity in the clinical response to costimulati...
Autores principales: | Edner, Natalie M, Wang, Chun Jing, Petersone, Lina, Walker, Lucy S K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613378/ https://www.ncbi.nlm.nih.gov/pubmed/36017489 http://dx.doi.org/10.1093/immadv/ltaa003 |
Ejemplares similares
-
Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity
por: Wang, Chun Jing, et al.
Publicado: (2022) -
Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes
por: Edner, Natalie M., et al.
Publicado: (2020) -
Author Correction: Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity
por: Wang, Chun Jing, et al.
Publicado: (2023) -
T Cell/B Cell Collaboration and Autoimmunity: An Intimate Relationship
por: Petersone, Lina, et al.
Publicado: (2018) -
Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood
por: Edner, Natalie M, et al.
Publicado: (2023)